Adma Biologics | ADMA - Cash And Equivalent

Stock Price
15.71
Daily Change
0.19 1.22%
Monthly
-7.37%
Yearly
-0.44%
Q1 Forecast
15.60

Adma Biologics reported $61.38M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Adma Biologics USD 61.38M 28.9M Sep/2025
Alnylam Pharmaceuticals USD 1.66B 167M Dec/2025
BioCryst Pharmaceuticals USD 84.08M 3.95M Sep/2025
Minerva Neurosciences USD 12.29M 2.96M Sep/2025
Novavax USD 268.02M 14.28M Sep/2025
Omeros USD 1.9M 2.36M Jun/2025
Takeda JPY 654.94B 26.55B Dec/2025